PAVmed (NASDAQ: PAVMU) is a multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The company’s goal is to enhance and accelerate value creation by employing a business model focused on … Continue reading →

Spring Bank Pharmaceuticals (NASDAQ: SBPH) is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. The company is developing its most … Continue reading →

IZEA, Inc. (NASDAQ: IZEA) has created and operates an online marketplace designed to connect brands with influential content creators. IZEA’s content creators range from leading bloggers and social media personalities to A-List celebrities and professional journalists. These creators are compensated … Continue reading →

Great Basin Scientific (NASDAQ: GBSN) is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. Great Basin’s … Continue reading →

Emerald Medical Applications (OTC: MRLA) owns the Dermacompare Medical App, a cloud-based, artificial intelligence technology that enables photos, taken from almost all digital cameras, to detect the suspicion of melanoma. The FDA-registered, HIPPA-compliant app, available from any App store, enables … Continue reading →

NXT-ID (NASDAQ: NXTD) is an emerging technology company focused on products, solutions, and services for security on mobile devices. Its core technologies consist of those that support digital payments, biometric identification, encryption, sensors, and miniaturization. The company is pursuing three … Continue reading →

Pyxis Tankers (NASDAQ: PXS) owns a modern fleet of six tankers engaged in the seaborne transportation of refined petroleum products and other bulk liquids. The company is focused on growing its fleet of medium range product tankers, which are designed … Continue reading →

Microlin Bio (OTC: MICBE) is an emerging therapeutics company focused on microRNA and its role in oncology. MicroRNAs are recently discovered, naturally occurring RNA molecules that do not encode proteins, but instead regulate gene expression and various biological pathways. Improper … Continue reading →

ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) is a Los Angeles-based clinical-stage company developing immune-based therapies for the treatment of brain and other cancers. The company has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine … Continue reading →

eWellness Healthcare (OTC: EWLL) is the first physical therapy telemedicine company to offer real-time, insurance reimbursable distance monitored treatments. The company’s business model is to license its PHZIO (“PHZIO”) platform to any physical therapy clinic in the U.S. and/or have large-scale … Continue reading →